Timothy C. Kennedy
2020
In 2020, Timothy C. Kennedy earned a total compensation of $1.1M as Chief Financial Officer, Chief Operating Officer at Biocept, a 33% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $150,000 |
|---|---|
| Option Awards | $596,474 |
| Salary | $344,877 |
| Other | $9,450 |
| Total | $1,100,801 |
Kennedy received $596.5K in option awards, accounting for 54% of the total pay in 2020.
Kennedy also received $150K in non-equity incentive plan, $344.9K in salary and $9.5K in other compensation.
Rankings
In 2020, Timothy C. Kennedy's compensation ranked 8,225th out of 13,090 executives tracked by ExecPay. In other words, Kennedy earned more than 37.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 8,225 out of 13,090 | 37th |
Division Services | 1,581 out of 2,338 | 32nd |
Major group Health Services | 175 out of 252 | 31st |
Industry group Medical And Dental Laboratories | 53 out of 73 | 27th |
Industry Medical Laboratories | 53 out of 73 | 27th |
Source: SEC filing on April 30, 2021.
Kennedy's colleagues
We found two more compensation records of executives who worked with Timothy C. Kennedy at Biocept in 2020.